(Q43545620)

24 November 2017

Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors (English)

1 reference

24 November 2017

0 references

1 reference

M H Nelson

1

1 reference

24 November 2017

A K Birnbaum

series ordinal

2

1 reference

24 November 2017

R P Remmel

series ordinal

3

1 reference

24 November 2017

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

44

1 reference

24 November 2017

71-82

1 reference

24 November 2017

1

1 reference

Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Age and phenytoin kinetics in adult epileptics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Allelic and functional variability of cytochrome P4502C9.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Interaction between phenytoin and fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

A review of the metabolism and pharmacokinetics of paroxetine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116)

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

Differential inhibitory effects of phenytoin, diclofenac, phenylbutazone and a series of sulfonam ides on hepatic cytochrom e P4502C activityin vitro, and correlation with som e m olecular descriptors in the dwarf goat (Caprus hircus aegagrus)

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900203-5

7 January 2021

10.1016/S0920-1211(00)00203-5

Identifiers

DOI

1 reference

release_ogc2xcxxmbhpvfci7vf7uwumw4

24 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ogc2xcxxmbhpvfci7vf7uwumw4

24 November 2022

mapped directly with Wikidata item

1 reference